The p16 Immunostaining Predicts the Risk of Recurrence in Prostate Cancer.Published in:Asian Pacific Journal of Cancer Prevention, 2025, v. 26, n. 1, p. 77, doi. 10.31557/APJCP.2025.26.1.77By:Carneiro de Andrade Cavalcante, Sara Lourrane;de Barros Silva, Paulo Goberlânio;Gustavo Hirth, Carlos;Sousa Frederico, Ingrid Kellen;Miranda Furtado, Cristiana Libardi;do Ó Pessoa, Cláudia;Vieira Barreto, Giulianna Aparecida;Gonzaga Silva, Lúcio FlávioPublication type:Article